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Introduction
Small ubiquitin-like modifi er proteins (SUMOs) are ubiquitinrelated proteins that act in many processes through covalent linkage to cellular proteins ( Johnson, 2004 ) . Mammalian cells express three major SUMO paralogues: mature SUMO-2 and SUMO-3 are ‫ف‬ 95% identical to each other and each is ‫ف‬ 45% identical to SUMO-1. (Where they cannot be distinguished, SUMO-2 and -3 will be collectively called SUMO-2/3.) SUMO-1 localizes within the nucleoplasm, nuclear envelope, and nucleolus, whereas SUMO-2 and SUMO-3 are predominantly found in the nucleoplasm ( Ayaydin and Dasso, 2004 ) . All newly synthesized SUMOs are processed by ubiquitin-like protein/ sentrin-specifi c proteases (Ulp/SENPs), and Ulp/SENPs also deconjugate SUMOylated species ( Hay, 2007 ; Mukhopadhyay and Dasso, 2007 ) . Saccharomyces cerevisiae has two Ulp/ SENPs, Ulp1p and Ulp2p Hochstrasser, 1999 , 2000 ) . Ulp1p is essential and localizes to nuclear pores, whereas Ulp2p is dispensable for growth and localizes to the nucleoplasm. Ulp1p has been particularly implicated in ribosome biogenesis ( Panse et al., 2006 ) .
The nucleolus is the site of ribosome synthesis, including preribosomal RNA transcription, ribosomal RNA (rRNA) processing, and ribosomal subunit assembly ( Boisvert et al., 2007 ) . B23/nucleophosmin is an abundant 37-kD phosphoprotein that shuttles between the granular component of the nucleolus and cytoplasm. B23/nucleophosmin can become SUMO conjugated under some circumstances ( Liu et al., 2007 ) . It has been implicated in many cellular processes, including ribosome biogenesis and export, centrosome duplication, and maintenance of genomic integrity through the Arf -MDM2 -p53 pathway ( Grisendi et al., 2006 ; Sherr, 2006 ) . Consistent with these diverse roles, U biquitin-like protein/sentrin-specifi c proteases (Ulp/SENPs) mediate both processing and deconjugation of small ubiquitin-like modifi er proteins (SUMOs). Here, we show that Ulp/SENP family members SENP3 and SENP5 localize within the granular component of the nucleolus, a subnucleolar compartment that contains B23/nucleophosmin. B23/nucleophosmin is an abundant shuttling phosphoprotein, which plays important roles in ribosome biogenesis and which has been strongly implicated in hematopoietic malignancies. Moreover, we found that B23/nucleophosmin binds SENP3 and SENP5 in Xenopus laevis egg extracts and that it is essential for stable accumulation of SENP3 and SENP5 in mammalian tissue culture cells. After either codepletion of SENP3 and SENP5 or depletion of B23/nucleophosmin, we observed accumulation of SUMO proteins within nucleoli. Finally, depletion of these Ulp/SENPs causes defects in ribosome biogenesis reminiscent of phenotypes observed in the absence of B23/nucleophosmin. Together, these results suggest that regulation of SUMO deconjugation may be a major facet of B23/nucleophosmin function in vivo.
granular component (dsRed-B23/nucleophosmin). The signal from GFP-SENP3 and GFP-SENP5 overlapped poorly with UBF staining and only partially with dsRed-fi brillarin, suggesting that they were not concentrated in either the fi brillar centers or the dense fi brillar component ( Fig. 1 A , top) . In contrast, both proteins showed distributions that were very similar to B23/ nucleophosmin, which could be observed either by immunostaining or by coexpression of B23/nucleophosmin as a fusion with the dsRed fl uorescent protein ( Fig. 1 A , bottom) . We conclude that SENP3 and SENP5 are concentrated within the granular component.
The presence of SUMO-2/3 -specifi c proteases within nucleoli suggested that the absence of these SUMO paralogues might be the result of their ongoing removal from nucleolar targets. To test this idea, we depleted SENP3 and SENP5 individually and together by oligonucleotide-mediated RNA interference (RNAi) from HeLa cells ( Fig. 2 A ) . Depletion of either protease did not substantially alter the distribution of SUMO proteins. However, nucleolar SUMO-1 increased after codepletion of SENP3 and SENP5 ( Fig. 2 B and Fig. S1 , available at http:// www.jcb.org/cgi/content/full/jcb.200807185/DC1). Signifi cantly, SUMO-2/3 also became concentrated within nucleoli in the absence of both enzymes. The redistribution of SUMO-2/3 was striking because these paralogues are normally not evident within nucleoli. Depletion of nuclear pore -associated SENP/Ulps (SENP1 and SENP2) did not increase nucleolar levels of SUMO proteins (unpublished data), arguing that such accumulation is not a general result of SUMO pathway manipulation or of RNAi machinery activation.
SENP3 and SENP5 show robust enzymatic activities against SUMO-2/3 -containing substrates ( Di Bacco et al., 2006 ;  B23/nucleophosmin binds to nucleic acids, nucleolar components, transcription factors, and histones, as well as to proteins involved in cell proliferation, mitosis, and oncogenic stress responses ( Grisendi et al., 2006 ) . It is not clear how these aspects of B23/nucleophosmin may be integrated with each other. Notably, B23/nucleophosmin is often overexpressed in solid tumors and has been strongly linked to hematopoietic malignancies ( Grisendi et al., 2006 ) .
We have examined the subnucleolar localization, behavior, and function of two nucleolar Ulp1p-like SUMO proteases, SENP3 and SENP5 ( Di Bacco et al., 2006 ; Gong and Yeh, 2006 ; Mukhopadhyay and Dasso, 2007 ) . We found that both of these enzymes colocalize and physically interact with B23/nucleophosmin. Moreover, B23/nucleophosmin is essential for their stable accumulation. After either codepletion of these Ulp/SENPs or depletion of B23/nucleophosmin, SUMO proteins accrue within nucleoli. Importantly, depletion of SENP3 and SENP5 causes defects in ribosome biogenesis reminiscent of those observed in the absence of B23/nucleophosmin. Collectively, our fi ndings indicate that regulation of SUMO deconjugation through SENP3 and SENP5 may be a major facet of B23/nucleophosmin function and suggest that at least some of the diverse phenotypes found after disruption of B23/nucleophosmin can be attributed to defects of SUMOylation.
Results and discussion
We compared the localization of stably expressed GFP-SENP3 and GFP-SENP5 with components that are characteristic of nucleolar subcompartments, including the fi brillar centers (anti-UBF), the dense fi brillar component (dsRed-fi brillarin), and the Figure 1 . SENP3 and SENP5 colocalize and associate with B23/nucleophosmin. (A) U2OS-derived cell lines expressing GFP-SENP3 and GFP-SENP5 were transfected with a plasmid for expression of dsRed-fi brillarin (top). After 48 h, the cells were fi xed and immunostained with monoclonal anti-UBF antibodies. The left column shows GFP, dsRed, and anti-UBF in the context of the nucleus, with DNA stained in blue using Hoechst 33342. The same cells were transfected with dsRed-B23/nucleophosmin (bottom). (B) Rabbit IgG (IgG), anti-xSENP3, or anti-xB23/nucleophosmin (xB23/NPM) antibodies were used for immunoprecipitation from 100 μ l of interphase XEE (top). The samples were subjected to SDS-PAGE and immunoblotting with anti-xSENP3 or anti-B23/nucleophosmin antibodies. To test xSENP5 binding to xB23/nucleophosmin, 25 μ l of XEE containing in vitro -translated FLAG-tagged xSENP5 was mixed with equal volume of interphase XEE. Immunoprecipitations were performed with anti-FLAG or anti-xB23/NPM antibodies (bottom). The samples were subjected to immunoblotting with anti-FLAG or anti-xB23/NPM antibodies. (C) Anti-xSENP3 was used for immunoprecipitation from IgG-treated control (+) or xB23/ NPM-depleted ( Ϫ ) XEEs. The samples were subjected to SDS-PAGE and Western blotting with anti-xSENP3, -Rpl26, -RplP0, or -xB23/ NPM antibodies, as indicated on the right. B23/NUCLEOPHOSMIN REGULATES SENP3 AND SENP5 • Yun et al.
that defects in ribosome biogenesis were specifi cally caused by depletion of SENP3 and SENP5. Our results show that SENP3 and SENP5 individually play important roles in ribosome biogenesis ( Fig. 3 ), but depletion of both proteases is required for elevation of SUMO-conjugated species within nucleoli ( Fig. 2 ) . Together, these results might suggest that although both SENP3 and SENP5 can act on the bulk of nucleolar substrates, they may each specifi cally regulate a subset of conjugates that are critical for particular events in the biogenesis pathway.
We were unable to extract SENP3 and SENP5 from mammalian nucleoli under conditions that would allow analysis of protein -protein interactions. As an alternative, we used Xenopus laevis egg extracts (XEEs) to look for binding partners. XEEs offer major advantages for these experiments because most nuclear and nucleolar proteins are stored in soluble forms ( Powers et al., 2001 ) . Human SENP3 and Xenopus SENP3 (xSENP3) proteins are ‫ف‬ 85% identical within their catalytic domains and 50% identical throughout their entire sequences. Human SENP5 and xSENP5 proteins are ‫ف‬ 87% identical within their catalytic domains and 43% identical throughout their entire sequences. There was little xSENP5 in Xenopus eggs (unpublished data), which is perhaps consistent with the more specialized tissue distribution of mammalian SENP5 (Fig. S2 C) . Antibodies against xSENP3 recognized a protein of the appropriate size in XEEs. Analysis using vinyl sulfone derivatives of different SUMO paralogues demonstrated that xSENP3 shared the same enzymatic specifi city as mammalian SENP3 (Fig. S2 D) .
We observed a protein that strongly and specifi cally coprecipitated with xSENP3, which mass spectrometric analysis revealed to be the Xenopus homologue of B23/nucleophosmin (xB23/nucleophosmin). We confi rmed this interaction by Western blotting of anti-xSENP3 immunoprecipitates ( Fig. 1 B ) . Given the low levels of xSENP5 within XEEs, we used an alternative strategy to determine whether SENP5 might likewise Gong and Yeh, 2006 ; Fig. S2 , available at http://www.jcb.org/cgi/ content/full/jcb.200807185/DC1), so they may directly control the half-lives of nucleolar SUMO-2/3 -conjugated species. The functions of SENP3 and SENP5 appear to be at least partially redundant because high levels of SUMO-2/3 did not accumulate unless both proteins were depleted. Their role in controlling nucleolar SUMO-1 accumulation is somewhat harder to understand. It is possible that deconjugation of multiple SUMO moieties from some targets must occur in a particular sequence, so that failure to remove SUMO-2/3 in the absence of SENP3 and SENP5 might block subsequent removal of SUMO-1, and thus indirectly result in its nucleolar accumulation. Alternatively, SENP3 and SENP5 may be more active in vivo against SUMO-1 -conjugated species than indicated by in vitro assays.
Budding yeast Ulp1p is required for 60S preribosome maturation and export ( Panse et al., 2006 ) . To test whether SENP3 and SENP5 are similarly required, we examined rRNA synthesis and processing through pulse-chase analysis with [ 3 H]uridine ( Fig. 3 ) . Although 47S rRNA transcription was not substantially decreased after SENP3 depletion, the production of 28S rRNA from their 32S precursor RNA was inhibited. After a 2-h chase, control cells showed a ratio of labeled 32S versus 28S RNAs that was less than 0.5:1, whereas this ratio was over 2:1 in SENP3-depleted cells ( Fig. 3 B ) . In contrast, loss of SENP5 did not have a strong effect on rRNA processing, but caused the levels of 47S RNA transcription to drop by > 60% ( Fig. 3 C ) . Cells depleted of both proteins showed both decreased 47S RNA precursor levels and increased 32S/28S ratios. Relocalization of ribosomal assembly factors further suggested disruption of ribosome biogenesis in the absence of SENP3 and SENP5 (Fig. S3 , available at http://www. jcb.org/cgi/content/full/jcb.200807185/DC1). Simultaneous depletion of SENP1 and SENP2 marginally reduced 47S RNA transcription but did not appreciably alter the rate of rRNA processing or alter assembly factor localization (unpublished data), arguing tion and phenotypic similarities, lead us to further examine their relationship. Both SENP3 and SENP5 levels decreased dramatically after RNAi-mediated depletion of B23/nucleophosmin ( Fig. 4 ) . This could be observed either by immunoblotting ( Fig. 4 A ) or by examination of GFP fl uorescence in U2OS cells stably expressing GFP-SENP3 or GFP-SENP5 ( Fig. 4 B ) . SENP1 and SENP2 levels did not change after B23/nucleophosmin depletion ( Fig. 4 A ) . As in experiments where SENP3 and SENP5 were codepleted ( Fig. 2 ) , depletion of B23/nucleophosmin caused a shift of SUMO protein distribution toward nucleoli ( Fig. 4 C ) . Our fi ndings suggest that B23/nucleophosmin physically interacts with SENP3 and SENP5 and regulates their abundance and that it thus plays a critical role in controlling the profi le of SUMO conjugates within nucleoli through SENP3 and SENP5.
Several observations indicated that SENP3 and SENP5 loss was caused by increased degradation rather than decreased expression. First, GFP-SENP3 and GFP-SENP5 were not transcribed from the native SENP3 and SENP5 promoters, so the drop in their levels upon B23/nucleophosmin depletion ( Fig. 4 B ) argues that repression of those promoters cannot account for changes in protein levels. Second, the concentrations of SENP3 and SENP5 mRNAs were not substantially altered by B23/ nucleophosmin depletion in HeLa cells, as measured by RT-PCR (unpublished data), further arguing against B23/nucleophosmin control of SENP3 and SENP5 transcription or mRNA stability. Third, B23/nucleophosmin-depleted cells did not show a substantial drop in overall protein translation, as measured by incorporation of [ 35 S]methionine (unpublished data), indicating that preexisting ribosomes were largely suffi cient to maintain protein synthesis levels. Notably, depletion of a key ribosomal assembly factor, Rrp9 ( Venema et al., 2000 ) , did not destabilize SENP3 and SENP5 or cause substantial nucleolar accumulation of SUMO proteins (unpublished data), demonstrating that their loss was not a simple consequence of ribosome synthesis inhibition but may be more specifi cally linked to the function of B23/nucleophosmin.
Finally, SENP3 and SENP5 levels in B23/nucleophosmindepleted cells showed substantial, albeit incomplete, recovery upon treatment with the proteasome inhibitor MG132, which is consistent with the notion that they are subject to degradation in the absence of B23/nucleophosmin ( Fig. 4 D ) . Stable cell lines expressing GFP-SENP3 and SENP5 showed a partial redistribution of GFP signals after B23/nucleophosmin depletion and MG132 treatment, with an increase in the ratio of nucleoplasmic to nucleolar distribution of both fusion proteins (unpublished data). This observation might indicate a role for B23/nucleophosmin in retention of these Ulp/SENPs within the nucleolus. However, we noted that the distribution of many other nucleolar proteins was rearranged after MG132 treatment, so it is also possible that relocalization of GFP-SENP3 and GFP-SENP5 may refl ect alterations of nucleolar structure.
We hypothesized that failure to deconjugate some SUMO species might disrupt ribosome biogenesis in the absence of SENP3 and SENP5. We therefore examined the SUMOylation of mammalian homologues of ribosomal proteins or ribosome assembly factors that have been implicated as SUMO conjugation targets in yeast ( Panse et al., 2004 ( Panse et al., , 2006 ; Wohlschlegel associate with xB23/nucleophosmin. FLAG-tagged xSENP5 was translated within XEEs ( Boyarchuk et al., 2007 ) , followed by precipitation with anti-FLAG or anti-xB23/nucleophosmin antibodies. Like xSENP3, we found that FLAG-tagged xSENP5 strongly bound with xB23/nucleophosmin in XEEs ( Fig. 1 B ) .
Mammalian cells lacking B23/nucleophosmin show defects in ribosome biogenesis and particularly in 32S to 28S RNA processing ( Itahana et al., 2003 ) . The association of B23/nucleophosmin and nucleolar SENPs, as well as their colocaliza- argued that SENP3 acts upstream of B23/nucleophosmin, causing inhibition of ribosome biogenesis through increased B23/nucleophosmin SUMOylation. In our hands, depletion of SENP3 and SENP5 by RNAi, either singly (not depicted) or in combination ( Fig. 5 ) , did not cause a substantial SUMOylation of B23/nucleophosmin. We do not know why our results differ from those of Denison et al., 2005 ; Hannich et al., 2005 ) . Using cells that stably expressed His 6 -tagged SUMO-1 (His-SUMO1F) or SUMO-2 (His-SUMO2F) proproteins, we examined changes in electrophoretic mobility of potential conjugation targets by Western blotting after codepletion of SENP3 and SENP5. We also purifi ed the SUMO-conjugated fraction from each cell line by affi nity chromatography and examined whether SUMOylated forms of the proteins could be found by Western analysis.
A subset of proteins showed clearly altered SUMOylation patterns under these circumstances: GNL2, the mammalian homologue of a 60S preribosomal export factor, showed a supershifted form upon depletion of SENP3/5 ( Fig. 5 ) , which was verifi ed as a SUMOylated form through its preferential retention on nickel -nitrilotriacetic acid (Ni-NTA) agarose beads. We observed a supershifted form of the 60S ribosomal subunit RPL37A that was retained on Ni-NTA agarose beads in the absence of SENP3/5 ( Fig. 5 , top) , suggesting that it was likewise subject to enhanced modifi cation. Other nucleolar proteins (fi brillarin, DDX3, DDX17, and NVL2; unpublished data) did not show evidence of SUMOylation in this assay. Although this is an incomplete survey of potential conjugation targets within the 60S ribosomal biogenesis pathway, it demonstrates that multiple pathway components are SUMOylation targets, as in yeast. More importantly, enhanced RPL37A and GNL2 SUMOylation after depletion of SENP3 and SENP5 implicates these proteases in the control of ribosome biogenesis through this modifi cation.
While this manuscript was under revision, Haindl et al. (2008) reported that SENP3 and B23/nucleophosmin physically interact and that loss of SENP3 disrupts rRNA processing. They . Enhanced SUMO modifi cation of RPL37A and GNL2 after depletion of SENP3 and SENP5. U2OS stably expressing full-length His-tagged versions of SUMO-1 and SUMO-2 (His-SUMO1F and His-SUMO2F) were transfected with siRNAs for codepletion of SENP3 and SENP5 or with control oligonucleotides. After 72 h, the cells were harvested and His 6 -SUMO -modifi ed proteins were isolated. Total cell extracts and His 6 affi nity fractions were analyzed by Western blotting with antibodies against RPL37A (top), GNL2 (middle), or B23/nucleophosmin (bottom).
Interactions of B23/nucleophosmin with SENP3 or SENP5
Interphase XEEs were prepared as described previously ( Orjalo et al., 2006 ) . For Fig. 1 B (top) , anti-xSENP3 and -xB23 antibodies or rabbit IgG were conjugated to protein A Dynabeads (Invitrogen). The XEE was supplemented with 10 μ g/ml each of leupeptin, pepstatin, and chymostatin and with 20 μ M Ran-Q69L ( Orjalo et al., 2006 ) and incubated with antibodycoated beads for 1 h at 23 ° C. The beads were washed with buffer A (250 mM sucrose, 2.5 mM MgCl 2 , 1 mM DTT, 100 mM KCl, and 10 mM Hepes, pH 7.7) plus 0.00001% digitonin and protease inhibitors and eluted with 25 μ l of 0.1 M glycine, pH 2.3. For Fig. 1 B (bottom) , pT7-FLAG-TR ␣ -xSENP5 mRNA was made using an mMessage mMACHINE T7 kit (Applied Biosystems) and translated in XEEs ( Boyarchuk et al., 2007 ) . 25 μ l of the reaction was mixed with 25 μ l of interphase XEE and 20 μ M Ran-Q69L. The mixture was diluted 10-fold with buffer B (250 mM sucrose, 2.5 mM MgCl 2 , 1 mM DTT, 50 mM KCl, 100 mM Hepes, pH 7.7, and 0.00001% digitonin) and clarifi ed by centrifugation. Mouse anti-FLAG antibody (M2; Sigma-Aldrich), rabbit anti-xB23, nonspecifi c mouse IgG, or nonspecifi c rabbit IgG were added to aliquots of the clarifi ed supernatant and incubated for 1 h on ice before addition of 15 μ l of preblocked protein G -Sepharose (GE Healthcare). After 1 h at 4 ° C with rotation, the beads were pelleted, washed with buffer A plus 0.00001% digitonin, and eluted with 25 μ l of 0.1 M glycine, pH 2.3.
In Fig. 1 C , interphase XEEs were depleted using protein A Dynabeads coupled with anti-xB23/nucleophosmin antibodies or mock treated with rabbit IgG-coupled control beads. Resultant XEEs were supplemented with protease inhibitors and 20 μ M Ran-Q69L, and immunoprecipitations with anti-xSENP3 antibody or rabbit IgG were performed as described in the previous paragraph. Bound proteins were eluted with 0.1 M glycine, pH 2.3.
In all cases, equal elution volumes were subjected to SDS-PAGE and Western blotting. In Fig. 1 , protein A -HRP was used for visualization of xSENP3. Anti-mouse IgG -HRP was used for FLAG epitope visualization. Anti-rabbit HRP was used for visualization of all other antibodies.
Immunofl uorescence microscopy and Western blotting Cells were grown on LabTeckII coverslip-bottomed chambers or glass slide coverslips. 72 h after transfection with siRNAs, cells were fi xed for 5 min with 4% formaldehyde in PBS and permeabilized for 5 min with 0.5% Triton X-100 in PBS. The cells were blocked for 1 h in PBS containing 1% bovine serum albumin. After washing with PBS, the cells were incubated with primary antibodies diluted 1:200 in blocking solution for 1 h. The coverslips were washed and incubated for 1 h with AlexaFluor 488 -conjugated Haindl et al. (2008) , but suspect that the relatively low levels of His-tagged SUMO proteins expressed in our stable cell lines may mimic physiological conditions more closely than conditions of transient expression. In any case, our results do not suggest that B23/nucleophosmin is itself the primary target of SENP3 or SENP5. As an alternative model, we note that B23/nucleophosmin interacts with ribosomes ( Grisendi et al., 2006 ) , so that it might act as an adaptor for targeting of SUMO proteases to ribosomal proteins. Consistent with this idea, 60S ribosomal components Rpl26 and RplP0 are coprecipitated from XEEs with xSENP3 in a xB23/ nucleophosmin-dependent manner ( Fig. 1 C ) .
The requirement for B23/nucleophosmin in ribosome synthesis has been proposed to include both action as an endonuclease ( Savkur and Olson, 1998 ) and as a chaperone ( Szebeni and Olson, 1999 ) . Our data show that regulation of SUMOylation through SENP3 and SENP5 is another major aspect of B23/ nucleophosmin function in this process. The capacity of xB23/ nucleophosmin to link xSENP3 with ribosomes suggests that it may recruit SUMO proteases to maturing ribosomal particles. Interestingly, B23/nucleophosmin has been implicated in a variety of apparently unrelated cellular processes ( Grisendi et al., 2006 ) , many of which are also dependent on the SUMO conjugation ( Hay, 2005 ) . We therefore speculate that altered SUMOylation may be a simple, unifying mechanism that underlies much of the apparent plurality of B23/nucleophosmin functions.
Materials and methods

Chemicals and reagents
Human testis QUICK-Clone cDNA, human multiple tissue cDNAs, pEGFP, and pDsRed were obtained from Clontech Laboratories, Inc. Oligofectamine, Rabbit IgG tricolor labeling kit, and geneticin were obtained from Invitrogen. siRNA oligonucleotides (SENP1, AATCCTTCCTCAGACAGTTTT; SENP2, AACATGCTGAAACTGGGTAAT; SENP3, AAACTCCGTACCAAGGGTTAT; SENP5, AAGTCCACTGGTCTCTCATTA; control, AACTGTCAGTCAGTC-GTAGTA), Ni-NTA agarose, and Effectene were obtained from QIAGEN. NHS-Sepharose, protein A -Sepharose, and HRP-conjugated secondary antibody were obtained from GE Healthcare. Mouse monoclonal anti-B23/nucleophosmin and anti-UBF antibodies were from Santa Cruz Biotechnology, Inc. Mouse monoclonal anti-GFP (JL-8) and rabbit anti-GFP (A.v) antibodies were obtained from BD and were used for Western blotting and immunoprecipitation, respectively. Mouse monoclonal anti-actin antibodies were obtained from Sigma-Aldrich. Rabbit anti-RPL37A and anti-GNL2 antibodies were obtained from Abnova. Rabbit anti-NVL antibodies were obtained from Proteintech Group, Inc. Rabbit polyclonal antibodies against Rpl26 and RplP0 were purchased from Bethyl Laboratories, Inc. and Proteintech Group, Inc., respectively. Rabbit antibodies against SUMO-1 and SUMO-2/3 were as described previously ( Azuma et al., 2003 ) . Other reagents were obtained from Sigma-Aldrich unless otherwise stated.
cDNA constructs
Human SENP3 and SENP5 complete coding sequences were amplifi ed from a testis cDNA library and subcloned into the XhoI -KpnI or HindIIIBamHI sites of pEGFP-C3, respectively. Full-length human fi brillarin and B23/nucleophosmin cDNAs were amplifi ed from a testis cDNA library and subcloned into the SalI -BamHI and XhoI -HindIII sites of pCMV-DsRedExpress vector, respectively. Full-length xSENP3 cDNA was obtained from American Type Culture Collection (IMAGE: 5155254). A full-length xSENP5 cDNA was amplifi ed from a tadpole cDNA library and subcloned into the XhoI -SpeI sites of pT7-FLAG-TR ␣ (a gift of Y.-B. Shi, National Institutes of Health, Bethesda, MD). This construct (pT7-FLAG-TR ␣ -XSENP5) was used for FLAG-tagged xSENP5 expression.
Antibodies and immunological methods
Human SENP3 (amino acids 204 -406) and SENP5 (amino acids 1 -237) fragments were subcloned into the BamHI -XhoI sites and BamHI -SalI sites
